Her Campus8h
4 Keys Ways RFK Jr. Could Impact College Students’ Health
With Robert F. Kennedy Jr. confirmed as the U.S. Health Secretary, here are some key ways he could impact college students' health.
Senate to vote on vaccine skeptic Robert F. Kennedy Jr.’s bid to become nation’s health secretary
The Senate is expected to vote Thursday on the confirmation of Robert F. Kennedy Jr., a prominent lawyer and vocal vaccine critic, as the nation’s health secretary, ...
Hosted on MSN4d
Wall Street Predict 92% Upside for This Dividend Stock: Should You Buy It Now?
Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.
Merck (MRK) Downgraded by TD Cowen Over Keytruda, Gardasil Concerns
We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...
HPV 'cures' are popping up online, but here's the truth about the STI and its vaccine
They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...
24/7 Wall St. on MSN7d
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?
Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name drugs such as Keytruda, and the myriad of commercials the company shows on ...
Merck Shares Hit After Guidance Falls Short, Gardasil Challenge
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
Merck Earnings: Gardasil Weighs on 2025 Growth, but Firm Still Undervalued
Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with ...
Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China
Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...
Merck stops Gardasil shipments to China, hitting 2025 outlook; shares tumble
Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...